SummerHaven Investment Management’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-17,083
Closed -$353K – 200
2025
Q2
$353K Buy
17,083
+777
+5% +$16.2K 0.23% 181
2025
Q1
$399K Buy
16,306
+522
+3% +$13.4K 0.28% 184
2024
Q4
$378K Hold
15,784
– – 0.23% 197
2024
Q3
$669K Buy
15,784
+8,760
+125% +$459K 0.41% 175
2024
Q2
$360K Buy
7,024
+278
+4% +$15.8K 0.24% 180
2024
Q1
$422K Buy
6,746
+123
+2% +$8.37K 0.26% 179
2023
Q4
$496K Buy
6,623
+155
+2% +$11.1K 0.32% 181
2023
Q3
$551K Buy
6,468
+674
+12% +$63.9K 0.4% 168
2023
Q2
$632K Sell
5,794
-1,357
-19% -$129K 0.4% 127
2023
Q1
$593K Buy
7,151
+194
+3% +$18.3K 0.35% 168
2022
Q4
$715K Buy
6,957
+93
+1% +$10.7K 0.43% 142
2022
Q3
$727K Buy
+6,864
New +$752K 0.5% 87
2021
Q3
– Sell
-9,745
Closed -$945K – 210
2021
Q2
$945K Buy
9,745
+234
+2% +$20.3K 0.54% 70
2021
Q1
$701K Hold
9,511
– – 0.43% 125
2020
Q4
$649K Buy
+9,511
New +$620K 0.5% 80

Other funds holding AMN

SummerHaven Investment Management's AMN Position: Q3 2025 in Review

SummerHaven Investment Management sold out of AMN Healthcare (AMN) in Q3 2025, closing a stake of 17,083 shares — an estimated $353K sold.

SummerHaven Investment Management first reported a position in AMN in Q4 2020 and held it in 15 quarters. The position peaked at $945K in Q2 2021. 249 funds tracked by Wall St. Rank hold AMN as of Q3 2025.

  • SummerHaven Investment Management reported no remaining AMN Healthcare position as of Q3 2025 after selling out during the quarter.
  • SummerHaven Investment Management sold 17,083 AMN Healthcare shares in Q3 2025, an estimated $353K.
  • SummerHaven Investment Management first reported a position in AMN Healthcare in Q4 2020 and held it in 15 quarters.
  • SummerHaven Investment Management's AMN Healthcare position peaked at $945K in Q2 2021.
  • 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q3 2025.

Based on SummerHaven Investment Management's 13F filing for Q3 2025, filed 3 Nov 2025.